NCT05563818View on ClinicalTrials.gov

Using Speech to Monitor Symptom Severity in Arabic Speaking Patients With Schizophrenia

CompletedOBSERVATIONAL
Enrollment

57

Participants

Timeline

Start Date

November 9, 2021

Primary Completion Date

December 20, 2022

Study Completion Date

December 20, 2022

Conditions
Schizophrenia
Interventions
OTHER

WinterLight Mobile Phone Speech Analysis

N/A- observational study

Trial Locations (4)

Unknown

Mustapha University Hospital, Algiers

Ain Shams Hospital, Cairo

Mental Health Hub, Amman

Jeddah Psychiatry Hospital, Jeddah

Sponsors
All Listed Sponsors
collaborator

Winterlight Labs

INDUSTRY

lead

Hikma Pharmaceuticals LLC

INDUSTRY

NCT05563818 - Using Speech to Monitor Symptom Severity in Arabic Speaking Patients With Schizophrenia | Biotech Hunter | Biotech Hunter